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Infusions of artichoke and milk thistle represent a
good source of phenolic acids and ﬂavonoids
Carla Pereira,a,b Lillian Barros,*a Ana Maria Carvalho,a Celestino Santos-Buelgab and
Isabel C. F. R. Ferreira*a
Cynara scolymus L. (artichoke) and Silybum marianum (L.) Gaertn (milk thistle) are two herbs well-known
for their eﬃciency in the prevention/treatment of liver injuries, among other chronic diseases. Therefore,
the aim of this work was to characterize speciﬁc bioactive components, phenolic compounds, in hydro-
methanolic extracts but also in infusions (the most commonly used preparations) obtained from the whole
plant of milk thistle and artichoke. The phenolic proﬁles were accessed using HPLC-DAD-MS/ESI. Infusions
of both species presented higher phenolic contents than the hydromethanolic extracts. Milk thistle pre-
sented a similar phenolic composition between the two preparations, revealing only diﬀerences in the
quantities obtained. Nevertheless, artichoke revealed a slightly diﬀerent proﬁle considering infusion and
hydromethanolic extracts. Apigenin-7-O-glucuronide was the major ﬂavonoid found in milk thistle, while
luteolin-7-O-glucuronide was the most abundant in artichoke. Therefore, infusions of both artichoke and
milk thistle represent a good source of bioactive compounds, especially phenolic acids and ﬂavonoids.
Introduction
The growing incidence of degenerative diseases, such as
cancers and cardiovascular diseases, has triggered an increas-
ing number of epidemiological studies on natural antioxidants
present in fruit and vegetables.1–3 Indeed, some studies
reported that societies whose diets are rich in these foods have
a low incidence of chronic diseases, which suggested that an
improved diet could reduce this kind of illness.4,5
Vegetables and derived products, such as infusions, have
been considered to be significantly important for the preven-
tion of cancer, diabetes, cardiovascular, inflammatory, allergic,
bacterial and viral diseases,6,7 and these health-promoting pro-
perties can be related to their extremely diverse phyto-
chemicals, particularly phenolic compounds that provide
preventive and defensive mechanisms to avoid chronic dis-
eases.8 These secondary metabolites of plants are well-known
for their dual role: as protective agents against oxidative
damage, mainly due to their redox capacity that allows them to
adsorb and neutralize free radicals, quench singlet and triplet
oxygen, or decompose peroxides; and as substrates for oxidative
browning reactions through enzymatic and chemical mecha-
nisms.9,10 Besides their strong antioxidant activity, phenolic
compounds also revealed a capacity to inhibit the growth of
tumor cell lines such as mammary, epidemoid, and hepatocel-
lular carcinoma, among others, in a large number of studies.11
Artichoke (Cynara scolymus L.) and milk thistle (Silybum
marianum (L.) Gaertn) are two medicinal plants in which
phenolic compositions of hydroalcoholic extracts were docu-
mented in diﬀerent studies12–17 due to their implication in
these herbs’ major medicinal properties, including antioxi-
dant, chemopreventive, hepatoprotective and antiviral.18,19
In previous studies, artichoke hydroalcoholic extracts have
proved to be a good source of flavonoids such as luteolin and
apigenin glycosides, and mono-/di-caﬀeoylquinic acids and
derivatives, the main factors responsible for its therapeutic
eﬀects.16,20 On the other hand, the medicinal properties of milk
thistle are attributed to a polyphenolic mixture known as sily-
marin (present in the seeds), which contains several flavono-
lignans that are diastereomeric and/or constitutional isomers of
each other, including silybin A, silybin B, isosilybin A, isosilybin B,
silychristin, isosilychristin, and silydianin.14,17,19,21–27
Artichoke and milk thistle can be directly consumed in the
diet or taken as infusions, among other available formu-
lations,18,28 allowing the dietary polyphenolic compounds to be
absorbed through the gastrointestinal tract to reach the liver,
where they are mainly metabolized.6 Thus, in the present work,
the aim was to obtain the phenolic profile of the most common
parts used to prepare the infusions of these plants instead of
their isolated parts that have already been well-reported as rich
sources of these bioactive compounds; for that purpose, the
aMountain Research Centre (CIMO), ESA, Polytechnic Institute of Bragança,
Campus de Santa Apolónia, Apartado 1172, 5301-855 Bragança, Portugal.
E-mail: iferreira@ipb.pt, lillian@ipb.pt; Fax: +351-273-325405;
Tel: +351-273-303219
bGIP-USAL, Faculty of Pharmacy, University of Salamanca, Campus Miguel de
Unamuno, 37007 Salamanca, Spain
56 | Food Funct., 2015, 6, 56–62 This journal is © The Royal Society of Chemistry 2015
Pu
bl
ish
ed
 o
n 
20
 O
ct
ob
er
 2
01
4.
 D
ow
nl
oa
de
d 
on
 1
9/
10
/2
01
5 
11
:2
4:
57
. 
View Article Online
View Journal  | View Issue
phenolic profiles of hydromethanolic extracts and infusions pre-
pared from the whole plant were assessed and compared.
Experimental
Samples
Cynara scolymus L. (artichoke) and Silybum marianum (L.)
Gaertn (milk thistle) were obtained from a herbalist shop in
Bragança (Portugal) as dry material (mainly flowering stems,
capitula and involucral bracts in both cases and leaves as well
in the Silybum sample). The botanical identification was con-
firmed by Ana Maria Carvalho, responsible for the medicinal
plant collection in the Herbarium of the Escola Superior
Agrária (BRESA) of the Polytechnic Institute of Bragança
(Trás-os-Montes, Portugal), where voucher specimens were de-
posited (artichoke – code 9611; milk thistle – code 9612).
All the samples were reduced to powder and subjected to
diﬀerent preparations: (i) Hydromethanolic extraction: each
sample (1 g) was extracted by stirring with 25 mL of methanol–
water (80 : 20, v/v, 25 °C at 150 rpm) for 1 h and subsequently fil-
tered through Whatman No. 4 paper. The residue was then
extracted with an additional 25 mL of methanol–water (80 : 20,
v/v) for another hour. The combined extracts were evaporated at
40 °C using a rotary evaporator (Büchi R-210, Flawil, Switzerland),
frozen and lyophilized; (ii) Infusion preparation: each sample
(1 g) was added to 200 mL of boiling distilled water and allowed
to stand at room temperature for 5 min, and then filtered under
reduced pressure; afterwards, the obtained infusion was frozen
and lyophilized (FreeZone 4.5, Labconco, Kansas City, MO, USA).
Standards and reagents
HPLC-grade acetonitrile was obtained from Merck KgaA
(Darmstadt, Germany). Formic acid was purchased from
Prolabo (VWR International, Fontenay-sous-Bois, France). Phe-
nolic standards were from Extrasynthèse (Genay, France).
Water was treated with a Milli-Q water purification system (TGI
Pure Water Systems, Greenville, SC, USA).
Phenolic compound extraction and analysis
The previously described hydromethanolic extracts and infu-
sions were dissolved in water–methanol (80 : 20, v/v) and water,
respectively (final concentration 20 mg mL−1) and analysed
using a Hewlett-Packard 1100 chromatograph (Hewlett-
Packard 1100, Agilent Technologies, Santa Clara, CA, US) with
a quaternary pump and a diode array detector (DAD) coupled
to an HP Chem Station (rev. A.05.04) data-processing station. A
Waters Spherisorb S3 ODS-2 C18, 3 μm (4.6 mm × 150 mm)
column thermostatted at 35 °C was used. The solvents used
were: (A) 0.1% formic acid in water and (B) acetonitrile. The
elution gradient established was isocratic 15% for 5 min,
15% B to 20% B over 5 min, 20–25% B over 10 min, 25–35% B
over 10 min, 35–50% for 10 min, and re-equilibration of the
column, using a flow rate of 0.5 mL min−1. Double online
detection was carried out in the DAD using 280 nm and
370 nm as preferred wavelengths and in a mass spectrometer
(MS) connected to an HPLC system via the DAD cell outlet.
MS detection was performed on an API 3200 Qtrap (Applied
Biosystems, Darmstadt, Germany) equipped with an ESI
source and a triple quadrupole ion trap mass analyzer that was
controlled using the Analyst 5.1 software. Zero grade air served
as the nebulizer gas (30 psi) and the turbo gas for solvent
drying (400 °C, 40 psi). Nitrogen served as the curtain (20 psi)
and collision gas (medium). The quadrupoles were set at unit
resolution. The ion spray voltage was set at −4500 V in the
negative mode. The MS detector was programmed for record-
ing in two consecutive modes: enhanced MS (EMS) and
enhanced product ion (EPI) analyses. EMS was employed to
show full scan spectra so as to obtain an overview of all of the
ions in the sample. The settings used were: declustering poten-
tial (DP) −450 V, entrance potential (EP) −6 V, and collision
energy (CE) −10 V. EPI mode analysis was performed in order to
obtain the fragmentation pattern of the parent ion(s) in the pre-
vious scan using the following parameters: DP −50 V, EP −6 V,
CE −25 V, and collision energy spread (CES) 0 V. Spectra were
recorded in negative ion mode between m/z 100 and 1500.
The phenolic compounds were identified by comparing
their retention time, UV-vis and mass spectra with those
obtained from standard compounds when available. Other-
wise, peaks were tentatively identified comparing the obtained
information with available data reported in the literature. For
the quantitative analysis, a calibration curve for each available
phenolic standard was constructed based on the UV signal:
apigenin-7-O-glucoside (y = 159.62x + 7.5025; R2 = 0.999);
caﬀeic acid (y = 611.9x − 4.5733; R2 = 0.999); chlorogenic acid
(y = 313.03x − 58.2; R2 = 0.999); p-coumaric (y = 884.6x +
184.49; R2 = 0.999); ferulic acid (y = 505.97x − 64.578); kaemp-
ferol-3-O-glucoside (y = 288.55x − 4.0503; R2 = 1); kaempferol-3-
O-rutinoside (y = 239.16x − 10.587; R2 = 1); luteolin-7-O-gluco-
side (y = 80.829x − 21.291; R2 = 0.999); protocatechuic acid
(y = 291.1x − 6.4558; R2 = 0.999); quercetin-3-O-glucoside (y =
363.45x + 117.86; R2 = 0.999), and quercetin-3-O-rutinoside (y =
281.98x − 0.3459; R2 = 1). For the identified phenolic com-
pounds for which a commercial standard was not available, the
quantification was performed through the calibration curve of
other compounds from the same phenolic group. The results
were expressed as mg per g of lyophilized infusion or extract.
Statistical analysis
For each species, three samples were used and all the analyses
were carried out in triplicate. The results were expressed as
mean values and standard deviation (SD) and further analysed
using one-way analysis of variance (ANOVA) followed by a
Tukey’s HSD test with α = 0.05. Their treatment was carried
out using the SPSS v.20.0 program.
Results and discussion
Tables 1 and 2 present the data obtained from an
HPLC-DAD-MS analysis (retention time, λmax in the visible
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region, mass spectral data) used for the identification and
quantification of phenolic compounds in S. marianum (milk
thistle) and C. scolymus (artichoke), respectively. As an
example, the HPLC phenolic profiles of their infusions,
recorded at 370 nm, can be observed in Fig. 1.
Phenolic acids
Protocatechuic acid (compound 3), 5-O-caﬀeolylquinic acid
(compound 6), quinic acid (compound 7), caﬀeic acid (com-
pound 8), and p-coumaric acid (compound 15) were positively
Table 1 Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, identiﬁcation and quantiﬁcation of
phenolic compounds in hydromethanolic extracts and infusion of artichoke (mean ± SD)a
Compound
Rt
(min)
λmax
(nm)
Molecular
ion [M − H]−
(m/z)
MS2 (m/z)
(% base peak)
Tentative
identification
Identification
type
Quantification (mg g−1)
Hydromethanolic Infusion
1 5.18 326 353 191(100), 179(63),
135(25)
3-O-Caﬀeoylquinic
acid
13, 15, 16, 31–40 0.10 ± 0.00 nd
2 5.58 262sh294 153 109(100) Dihydroxybenzoic acid DAD/MS nd 0.85 ± 0.02
3 6.18 262sh296 153 109(100) Protocatechuic acid Standard/DAD/MS 0.25 ± 0.01 0.23 ± 0.01
4 6.84 310 337 191(13), 173(6),
163(96), 155(6),
119(33)
3-p-Coumaroylquinic
acid
16, 29, 42 0.07 ± 0.00 nd
5 7.37 328 341 179(100), 135(89) Caﬀeic acid hexoside 16 0.13 ± 0.00 0.07 ± 0.00
6 7.92 326 353 191(100), 179(2),
161(2), 135(3)
5-O-Caﬀeoylquinic acid Standard/DAD/MS 0.49 ± 0.01 nd
7 8.44 286/333 191 175(100), 148(33),
103(6)
Quinic acid Standard/DAD/MS 0.21 ± 0.01 0.08 ± 0.00
8 10.66 324 179 135(100) Caﬀeic acid Standard/DAD/MS nd 0.51 ± 0.01
9 10.67 306 337 191(5), 173(100),
163(18), 155(5),
119(10)
4-p-Coumaroylquinic
acid
29, 42, Standard/
DAD/MS
0.12 ± 0.00 nd
10 11.21 324 515 353(95), 191(100),
179(65), 135(40)
1,3-Dicaﬀeoylquinic
acid
13, 15, 16, 31–40 0.37 ± 0.02 0.90 ± 0.02
11 12.95 312 337 191(100), 173(6),
163(10), 119(4)
cis 5-p-Coumaroylquinic
acid
29, 42, Standard/
DAD/MS
0.33 ± 0.02 nd
12 13.19 356 639 477(80), 315(51) Methylquercetin-O-
hexoside-O-hexoside
DAD/MS nd 0.14 ± 0.01
13 13.90 306 337 191(100), 173(3),
163(4), 119(2)
trans 5-p-Coumaroylquinic
acid
29, 42, Standard/
DAD/MS
0.03 ± 0.00 nd
15 16.81 310 163 119(100) p-Coumaric acid Standard/DAD/MS nd 0.40 ± 0.00
16 17.02 350 623 461(7), 285(100) Luteolin-O-hexoside-
O-glucuronide
16, DAD/MS 0.26 ± 0.01 0.46 ± 0.01
17 19.26 350 477 301(100) Quercetin-3-O-glucuronide Standard/DAD/MS 0.06 ± 0.00 0.09 ± 0.00
18 20.26 340 607 269(100) Apigenin-4-O-hexoside-7-
O-glucuronide
16, DAD/MS 0.12 ± 0.00 0.31 ± 0.02
20 20.70 344 461 285(100) Luteolin-7-O-glucuronide 13, 15, 16, 32, 33,
35–37, 39, 40
0.70 ± 0.02 5.64 ± 0.28
21 21.07 348 447 285(100) Luteolin-7-O-glucoside Standard/DAD/MS 0.49 ± 0.01 2.88 ± 0.05
22 22.95 330 515 353(68), 191(100),
179(20), 173(5),
161(10), 135(7)
3,5-O-Dicaﬀeoylquinic
acid
13, 15, 16, 31–40 nd 0.36 ± 0.00
24 24.01 338 577 269(100) Apigenin-7-O-rutinoside 13, 15, 16, 32, 33,
35–37, 39, 40
0.09 ± 0.02 0.16 ± 0.02
25 24.38 352 623 315(16), 300(56) Methylquercetin-O-
rutinoside
DAD/MS 0.08 ± 0.00 0.07 ± 0.00
26 25.51 336 445 269(100) Apigenin-7-O-glucuronide 13, 15, 16, 32, 33,
35–37, 39, 40
0.20 ± 0.00 1.24 ± 0.12
27 25.67 338 431 269(100) Apigenin-7-O-glucoside Standard/DAD/MS 0.21 ± 0.01 0.68 ± 0.02
28 29.30 340 431 285(100) Kaempferol-O-
deoxyhexosyl
DAD/MS 0.04 ± 0.01 0.06 ± 0.00
29 34.51 346 285 175(8), 151(8),
133(5)
Luteolin Standard/DAD/MS nd 0.14 ± 0.01
Total phenolic acids 2.12 ± 0.04b 3.40 ± 0.06a
Total flavonoids 2.25 ± 0.01b 11.89 ± 0.39a
Total phenolic
compounds
4.37 ± 0.05b 15.29 ± 0.33a
a nd, not detected; in each row, diﬀerent letters mean significant diﬀerences (p < 0.05).
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identified according to their retention time, mass and UV-vis
characteristics by a comparison with commercial standards.
Hydroxycinnamic acid derivatives were detected in both
samples, being mostly quinic acid derivatives, whose identities
were assigned based on their MS spectra and fragmentation
patterns. The assignments of the diﬀerent caﬀeoylquinic,
feruloylquinic and p-coumaroylquinic acid isomers were made
using the recommended IUPAC numbering system and also
the hierarchical keys previously developed by Cliﬀord et al.29,30
Compound 1 ([M – H]− at m/z 353) was identified as 3-O-
caﬀeoylquinic acid, yielding the base peak at m/z 191 ([quinic
acid-H]−) and the ion at m/z 179 ([caﬀeic acid-H]−) with an
intensity >63% base peak, characteristic of 3-acylchlorogenic
acids as reported by Cliﬀord et al.29,30 Monocaﬀeoylquinic
acids have been largely reported by many authors in diﬀerent
parts of artichoke, such as heads and leaves,13,15,31–38 hearts,16
wastes such as bracts, receptacles and stems from the fruit,39
juices and pomace,15,32 and in dietary supplements.15,37,40
Compound 22 present in milk thistle and artichoke was
identified as 3,5-O-dicaﬀeoylquinic acid based on its fragmen-
tation pattern being similar to that reported by Cliﬀord et al.30
The MS2 base peak was at m/z 191, but also presented a very
high relative abundance at m/z 353, produced by the loss of
one of the caﬀeoyl moieties [M − H-caﬀeoyl]−, whose sub-
sequent fragmentation yielded the same fragments as 5-O-
caﬀeoylquinic acid at m/z 191, 179 and 135. Compound 10
(artichoke) was identified as 1,3-O-dicaﬀeoylquinic acid
(cynarin) according to its MS2 fragmentation and elution
characteristics, being the most hydrophilic dicaﬀeoylquinic
acid.41 Dicaﬀeoylquinic acids have been extensively reported in
Table 2 Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, identiﬁcation and quantiﬁcation of
phenolic compounds in hydromethanolic extract and infusion of milk thistle (mean ± SD)a
Compound
Rt
(min)
λmax
(nm)
Molecular ion
[M − H]−
(m/z)
MS2 (m/z)
(% base peak)
Tentative
identification
Identification
type
Quantification (mg g−1)
Hydromethanolic Infusion
3 6.19 262sh296 153 109(100) Protocatechuic acid Standard/DAD/MS 0.44 ± 0.01 0.08 ± 0.01
5 7.44 328 341 179(100), 135(22) Caﬀeic acid hexoside DAD/MS 0.12 ± 0.00 0.05 ± 0.01
6 8.11 326 353 191(100), 179(4),
173(7), 135(5)
5-O-Caﬀeolyquinic acid Standard/DAD/MS 0.56 ± 0.02 0.15 ± 0.02
13 13.19 312 337 191(100), 173(7),
163(9), 119(5)
5-p-Coumarolyquinic acid 29, 42, Standard/
DAD/MS
0.12 ± 0.00 0.03 ± 0.01
14 15.02 328 367 193(43), 191(100),
173(11), 134(2)
5-O-Feruloylquinic acid DAD/MS 0.05 ± 0.01 0.05 ± 0.01
15 17.10 306 163 119(100) p-Coumaric acid Standard/DAD/MS 0.11 ± 0.01 0.11 ± 0.01
19 20.27 322 661 499(100), 337(11),
179(11), 173(87),
163(14), 119(8)
5-p-Coumarolyquinic
acid dihexoside
DAD/MS 0.11 ± 0.00 0.38 ± 0.03
20 20.77 350 461 285(100) Luteolin-7-O-glucuronide DAD/MS 0.58 ± 0.01 1.17 ± 0.09
22 23.03 330 515 353(71), 191(100),
179(6), 173(6),
135(6)
3,5-O-Dicaﬀeolyquinic
acid
30, Standard/
DAD/MS
0.13 ± 0.01 0.09 ± 0.02
23 23.95 336 591 269(100) Apigenin-O-deoxyhexosyl-
glucuronide
DAD/MS 0.10 ± 0.01 0.36 ± 0.02
26 25.48 338 445 269(100) Apigenin-7-O-glucuronide DAD/MS 1.26 ± 0.01 3.14 ± 0.12
Total phenolic acids 1.65 ± 0.04a 0.91 ± 0.09b
Total flavonoids 1.94 ± 0.01b 4.66 ± 0.18a
Total phenolic compounds 3.56 ± 0.05b 5.57 ± 0.27a
a In each row, diﬀerent letters mean significant diﬀerences (p < 0.05).
Fig. 1 Phenolic proﬁle of the infusion of artichoke (A) and milk thistle
(B) recorded at 370 nm. The proﬁle was obtained using a Spherisorb S3
ODS-2 C18 column thermostatted at 35 °C using a ﬂow rate of 0.5 mL
min−1 and with gradient elution: (a) 0.1% formic acid in water and
(b) acetonitrile.
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hydroalcoholic extracts obtained from diﬀerent parts of arti-
choke, as mentioned above.13,15,16,31–36,38–40
Four signals in artichoke (compounds 4, 9, 11 and 13)
showed a pseudomolecular ion ([M − H]−) at m/z 337 (Tables 1
and 2). These compounds were assigned as the 3-acyl, 4-acyl
and 5-acyl isomers of p-coumaroylquinic acid based on their
HPLC retention and MS2 fragmentation characteristics, as pre-
viously reported by Cliﬀord et al.29,42 Thus, compound 4 (arti-
choke) was tentatively identified as 3-p-coumaroylquinic acid,
yielding the base peak at m/z 163 ([coumaric acid-H]−). Frag-
mentation of compound 9 with a majority MS2 product ion at
m/z 173 was coherent with 4-p-coumaroylquinic acid, whereas
compound 13 (artichoke and milk thistle), yielding the base
peak at m/z 191, was identified as trans 5-p-coumaroylquinic
acid. The latter compound was also found in the analyzed
milk thistle extracts. Compound 11 (artichoke) with a UV spec-
trum and a MS2 fragmentation pattern identical to that of
compound 13 was tentatively assigned as the cis isomer of 5-p-
coumaroylquinic acid. This tentative assignment was sup-
ported by the observation that hydroxycinnamoyl cis deriva-
tives are expected to elute before the corresponding trans ones,
as previously observed before and after UV irradiation
(366 nm, 24 h) of hydroxycinnamic derivatives in our labora-
tory.43 Furthermore, in milk thistle, compound 19 with 162 +
162 mu (glucosyl moieties) higher than compound 13 was ten-
tatively identified as 5-p-coumarolyquinic acid dihexoside
(Table 1). As far as we are aware, except for 3-p-coumaroyl-
quinic acid identified in artichoke heart by Abu-Reidah
et al.,16 none of these p-coumaroylquinic acid derivatives has
been previously reported either in artichoke or in milk thistle.
Compound 14 in milk thistle was identified as 5-O-feruloyl-
quinic acid taking into account its pseudomolecular ion
([M − H]− at m/z 367) and MS2 fragmentation similar to that of
5-O-caﬀeoylquinic acid. This compound was previously identi-
fied in artichoke samples,16,37 but, as far as we know, it has
not been reported in milk thistle.
Compound 5 present in milk thistle and artichoke showed
a pseudomolecular ion [M − H]− at m/z 341, releasing an MS2
fragment at m/z 179 ([caﬀeic acid-H]−) from the loss of a
hexosyl moiety (−162 mu) that was tentatively assigned as
caﬀeic acid hexoside. That compound was also identified in
hydroalcoholic extracts of artichoke hearts by Abu-Reidah
et al.16
Finally, compound 2 (artichoke) with the same UV and
mass characteristics as compound 3 (protocatechuic acid, i.e.
3,4-dihydroxybenzoic acid) was just tentatively assigned as a
dihydroxybenzoic acid. Protocatechuic acid was previously
reported in hydroalcoholic extracts of artichoke wastes (bracts,
receptacles and stems from the fruit) by Sánchez-Rabaneda
et al.39
Flavonoids
Compounds 16, 21 and 29 in artichoke and compound 20 in
both samples were identified as luteolin derivatives according
to their UV and mass spectra characteristics (Tables 1 and 2).
Compounds 21 and 29 were positively identified as luteolin-7-
O-glucoside (cynaroside) and luteolin, respectively, by a com-
parison with commercial standards, being also largely identi-
fied in artichoke hearts,16 leaves and heads,13,15,31,32,34–37
juices and pomace,15,32 and dietary supplements.15,37,40
Compound 20 presented a pseudomolecular ion [M − H]−
at m/z 461 releasing a fragment ion at m/z 285 ([M − 176]−, loss
of a glucuronyl moiety); although the position of the glycosyl
moiety could not be established it was assigned to luteolin
7-O-glucuronide, owing to the identification of that compound
in leaves, heads, hearts, juices, pomaces and dietary sup-
plements of artichoke, mostly obtained after hydroalcoholic
extraction.13,15,16,32,33,35–37,39,40 Compound 16 presented a
pseudomolecular ion [M − H]− at m/z 623, yielding fragment
ions at m/z 461 (−162 mu; loss of a hexosyl residue) and 285
(−176 mu; loss of a glucuronyl residue), which allowed its
assignment as luteolin-O-hexoside-O-glucuronide. Two com-
pounds with similar characteristics were reported by
Abu-Reidah et al.,16 in artichoke hearts, without assigning the
position of substitution of the glycosyl residues.
In accordance with their UV and mass spectra character-
istics, diﬀerent apigenin derivatives were also detected in the
analysed samples. Compounds 24, 27 (artichoke) and 26 (arti-
choke and milk thistle) showed pseudomolecular and frag-
ment ions coherent with deoxyhexosyl-hexoside, hexoside and
glucuronide derivatives of apigenin, respectively. The presence
of apigenin-7-O-rutinoside, apigenin-7-O-glucuronide and api-
genin-7-O-glucoside in diﬀerent parts of artichoke was consist-
ently reported by the previously mentioned authors, so that
those identities could also be tentatively assumed for the com-
pounds detected herein. Furthermore, the identity of apigenin-
7-O-glucoside (compound 27) was here confirmed by a com-
parison with a commercial standard.
The pseudomolecular ion of compound 18 in artichoke
([M − H]− at m/z 607) released a fragment ion at m/z 269
([M − 162–176]−; apigenin), which allowed its tentative identi-
fication as an apigenin-O-hexoside-O-glucuronide. A com-
pound with similar characteristics was identified as apigenin-
4-O-hexoside-7-O-glucuronide by Abu-Reidah et al.16 in arti-
choke hearts. Another apigenin derivative (compound 23) was
detected in the sample of milk thistle, whose mass character-
istics ([M − H]− at m/z 591 releasing a fragment ion at m/z 269
([M − 146–176]−) from the loss of deoxyhexosyl and glucuronyl
moieties) pointed to an apigenin-O-deoxyhexosyl-glucuronide.
To our knowledge, this compound has not been previously
described in milk thistle samples.
The following compounds were only present in artichoke.
Compound 17 ([M − H]− at m/z 477) presented UV spectra with
λmax around 350 nm and an MS
2 product ion at m/z 301; com-
parison with a standard obtained in our laboratory44 allowed
its identification as quercetin 3-O-glucuronide. Compound 12
([M − H]− at m/z 639) released fragment ions at m/z 477 and
315, from the consecutive losses of 162 mu (two hexosyl moi-
eties). The ion at m/z 315 can be attributed to a methylquerce-
tin, whilst the high abundance of the ion at m/z 477 indicated
that each hexosyl group was located at diﬀerent positions of
the aglycone. Therefore, the compound was tentatively
Paper Food & Function
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assigned as methylquercetin-O-hexoside-O-hexoside. Com-
pound 25 ([M − H]− at m/z 623) released fragment ions at m/z
315 and 300 (further loss of a methyl group) also suggesting a
methylquercetin. In this case, the loss of 308 mu (146 +
162 mu) to yield the aglycone suggested the existence of deoxy-
hexose and hexose as glycosylating substituents, probably con-
stituting a disaccharide owing to their joint loss. Although
there was no further indication of the type of sugar, it might
be a rutinose taking into account the previous identification of
quercetin-3-O-rutinoside in hydroalcoholic extracts of arti-
choke samples by Sánchez-Rabaneda et al.39 and Abu-Reidah
et al.16 Thus, the compound was tentatively assigned as
methylquercetin O-rutinoside. Finally, compound 28 with a
pseudomolecular ion [M − H]− at m/z 431 yielding a product
ion at m/z 285 (−146 mu, loss of a deoxyhexosyl moiety) could
be associated with a kaempferol-O-deoxyhexoside. As far as we
know, none of the latter four compounds has been described
in artichoke.
In both species, infusions presented higher phenolic con-
tents than their hydromethanolic extracts. Milk thistle prep-
arations presented the same composition, revealing only
diﬀerences in the quantities obtained. Nevertheless, artichoke
revealed a diﬀerent profile between infusions and hydrometha-
nolic extracts. These diﬀerences can be mainly due to the heat
treatment to which infusions were subjected. Apigenin-7-O-glu-
curonide was the major flavonoid found in milk thistle
(Table 1), while luteolin-7-O-glucuronide was the most abun-
dant in artichoke (Table 2).
In the literature, the milk thistle phenolic composition
is characterized by seven flavonolignans
(silymarin).12,14,17,19,21,23–27,31 These compounds are known to
be normally present in seeds of milk thistle.17,19 Therefore, it
can be concluded that the sample studied by us did not
contain seeds, but only the other parts of the plant, even
though the label mentioned the whole plant material.
Despite the many articles reporting the phenolic compo-
sition of artichoke hydroalcoholic extracts,13,15,16,31–40 the
present work characterizes the phenolic composition in infu-
sions. Moreover, infusion is the most common form to
consume this plant and, to our knowledge, this is also the first
report presenting results for the whole plant material and not
seeds. The literature reports mainly the existence of caﬀeoyl-
quinic acid, and luteolin and apigenin derivatives, as also
observed in the present study. Nevertheless, the studied
sample of artichoke also presented other compounds.
Conclusions
Overall, both artichoke and milk thistle represent a good
source of bioactive compounds, especially phenolic acids and
flavonoids, that are more enhanced in the infusion prep-
arations. This study also provides the reason for the traditional
and current use of these plants in diﬀerent formulations (dry
material, pills and syrups) by deepening our knowledge of the
main responsible bioactive compounds. Moreover, these
plants can be used not only as excellent sources of antioxi-
dants but also as potential natural remedies that can be easily
included in the diet, thereby preventing and healing chronic
diseases.
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